Rocket Pharmaceuticals, Inc. SEC filings RCKT
Rocket Pharmaceuticals, Inc. has 968 filings in SEC EDGAR's recent list, going back to Feb 25, 2004. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 25-NSE | Delisting notice | Sep 2, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| S-8 | Employee stock plan registration | Jul 14, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Jun 12, 2026 | Jun 10, 2026 |
| SC TO-I/A | Filing | May 28, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 28, 2026 | Apr 26, 2026 |
| SC TO-I | Filing | Apr 27, 2026 | — |
| ARS | Annual report to shareholders | Apr 6, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 6, 2026 | May 20, 2026 |
| SC TO-C | Filing | Apr 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2026 | Mar 26, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 25, 2026 | May 20, 2026 |
| EFFECT | Filing | Mar 10, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 10, 2026 | Mar 10, 2026 |
| 424B5 | Prospectus supplement | Mar 10, 2026 | — |
| CORRESP | Letter to the SEC | Mar 6, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2026 | — |
| S-3 | Shelf registration | Mar 2, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Oct 3, 2025 | Oct 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 17, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2025 | Aug 20, 2025 |
| 8-K |
Current report
Other events
|
Aug 20, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Exit or restructuring costs
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Other events
|
Jul 17, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2025 | Apr 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2025 | Apr 7, 2025 |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2025 | Jan 25, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 12, 2024 | Dec 9, 2024 |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 424B5 | Prospectus supplement | Dec 10, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 18, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2024 | Sep 5, 2024 |
| S-3ASR | Automatic shelf registration | Aug 16, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Other events
|
Jun 28, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2024 | Jun 13, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 13, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2024 | Mar 25, 2024 |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2023 | Dec 7, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 2, 2023 | Oct 2, 2023 |
| 424B5 | Prospectus supplement | Sep 20, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 15, 2023 | Sep 12, 2023 |
| 424B5 | Prospectus supplement | Sep 13, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 13, 2023 | Sep 12, 2023 |
| 424B5 | Prospectus supplement | Sep 12, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2023 | Sep 12, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2023 | Jun 22, 2023 |
| EFFECT | Filing | May 8, 2023 | — |
| 10-Q | Quarterly report | May 5, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| POS AM | Filing | Apr 5, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 4, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| CERT | Filing | Feb 24, 2023 | — |
| 8-A12B | Filing | Feb 24, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 22, 2022 | Dec 22, 2022 |
| S-8 | Employee stock plan registration | Dec 20, 2022 | — |
| 8-K |
Current report
Acquisition or sale of assets, Shareholder vote results, Other events
|
Dec 1, 2022 | Nov 30, 2022 |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| EFFECT | Filing | Oct 31, 2022 | — |
| 424B3 | Prospectus | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 27, 2022 | — |
| S-4/A | Filing | Oct 27, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| S-4 | Registration for a merger or exchange | Oct 13, 2022 | — |
| 8-K |
Current report
Material agreement
|
Oct 4, 2022 | Oct 3, 2022 |
| 424B5 | Prospectus supplement | Oct 4, 2022 | — |
| 424B5 | Prospectus supplement | Oct 3, 2022 | — |
| 8-K |
Current report
Other events
|
Oct 3, 2022 | Sep 30, 2022 |
| 425 | Filing | Sep 20, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 20, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Other events
|
Sep 9, 2022 | Sep 9, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 13, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 1, 2022 | Feb 28, 2022 |
| 424B5 | Prospectus supplement | Mar 1, 2022 | — |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Nov 5, 2021 | Jun 14, 2021 |
| 10-Q | Quarterly report | Nov 5, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 3, 2021 |
| UPLOAD | Letter from the SEC | Oct 18, 2021 | — |
| CORRESP | Letter to the SEC | Oct 7, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| EFFECT | Filing | Sep 10, 2021 | — |
| CORRESP | Letter to the SEC | Sep 8, 2021 | — |
| S-3/A | Filing | Sep 3, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 30, 2021 | Aug 27, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 14, 2021 |
| S-3/A | Filing | May 10, 2021 | — |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 14, 2021 |
| 8-K |
Current report
Other events
|
Apr 27, 2021 | Mar 26, 2021 |
| UPLOAD | Letter from the SEC | Mar 10, 2021 | — |
| DEL AM | Filing | Mar 8, 2021 | — |
| S-3 | Shelf registration | Mar 2, 2021 | — |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2021 | Jan 4, 2021 |
| 8-K/A |
Amended current report
Other events
|
Dec 11, 2020 | Dec 6, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 11, 2020 | Dec 9, 2020 |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| S-3MEF | Filing | Dec 9, 2020 | — |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 9, 2020 | Dec 6, 2020 |
| 10-Q | Quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 12, 2020 | Jun 12, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 8, 2020 | Jun 5, 2020 |
| PX14A6G | Filing | May 29, 2020 | — |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Other events
|
May 1, 2020 | Apr 28, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2020 | Apr 20, 2020 |
| S-8 | Employee stock plan registration | Mar 6, 2020 | — |
| 10-K | Annual report | Mar 6, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 20, 2020 | Feb 18, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 11, 2020 | Feb 10, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 13, 2019 | Dec 10, 2019 |
| 424B5 | Prospectus supplement | Dec 11, 2019 | — |
| 424B5 | Prospectus supplement | Dec 10, 2019 | — |
| 10-Q | Quarterly report | Nov 8, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 31, 2019 | Oct 28, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| EFFECT | Filing | Jun 24, 2019 | — |
| CORRESP | Letter to the SEC | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2019 | — |
| 8-K |
Current report
Listing notice
|
Jun 19, 2019 | Jun 18, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 19, 2019 | Jun 17, 2019 |
| S-3 | Shelf registration | Jun 17, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2019 | — |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 17, 2019 |
| 8-K |
Current report
Material agreement
|
Apr 18, 2019 | Apr 15, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RCKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1281895
- Former names
- INOTEK PHARMACEUTICALS CORP (until Dec 22, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.